As COVID Vaccines Fast Approach for Adults, Researchers Prepare for Large-Scale Growth in Pediatrics Share Article Pediatric vaccine development has been one of the fastest growing areas in clinical research prior to the COVID-19 pandemic. Platinum Research Network has been actively supporting Phase I-III COVID-19 vaccine trials in adults and is fully prepared for upcoming trials in pediatric age groups. These trials are necessary to efficiently bring life-changing vaccines to the market. Platinum Research Network Kip McKenzie, President of Tekton Research, states, “Through the strength and collaborative relationships with Sponsors and CRO’s and extensive experience with enrollment of pediatric studies, we are prepared to successfully enroll pediatric COVID-19 trials.”